Colgate-Palmolive (NYSE:CL) Shares Sold by Van Cleef Asset Management Inc

Van Cleef Asset Management Inc trimmed its position in Colgate-Palmolive (NYSE:CL) by 16.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,150 shares of the company’s stock after selling 6,450 shares during the period. Van Cleef Asset Management Inc’s holdings in Colgate-Palmolive were worth $2,642,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of CL. &PARTNERS increased its position in Colgate-Palmolive by 0.7% in the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after buying an additional 129 shares during the period. West Branch Capital LLC increased its holdings in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after acquiring an additional 132 shares during the period. First Foundation Advisors lifted its position in Colgate-Palmolive by 2.7% in the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after purchasing an additional 136 shares during the last quarter. Waldron Private Wealth LLC grew its position in Colgate-Palmolive by 2.7% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares during the last quarter. Finally, Autumn Glory Partners LLC increased its stake in shares of Colgate-Palmolive by 2.7% in the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock valued at $424,000 after purchasing an additional 140 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Gregory Malcolm sold 8,930 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at approximately $686,470.05. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock worth $19,505,099 over the last 90 days. 0.34% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CL. The Goldman Sachs Group began coverage on Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price on the stock. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Stifel Nicolaus raised their target price on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. Finally, Wells Fargo & Company raised their price objective on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research note on Monday, January 29th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $89.50.

Colgate-Palmolive Trading Up 0.5 %

Colgate-Palmolive stock traded up $0.40 during midday trading on Thursday, reaching $89.27. The stock had a trading volume of 6,361,812 shares, compared to its average volume of 4,572,863. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $90.37. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The firm has a market cap of $73.38 billion, a price-to-earnings ratio of 31.97, a PEG ratio of 3.33 and a beta of 0.42. The firm’s fifty day simple moving average is $87.40 and its two-hundred day simple moving average is $81.25.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.89 billion. During the same period last year, the company posted $0.77 EPS. The business’s quarterly revenue was up 6.9% compared to the same quarter last year. Equities analysts anticipate that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.24%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 71.94%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.